146 related articles for article (PubMed ID: 17963689)
1. uPA binding increases UPAR localization to lipid rafts and modifies the receptor microdomain composition.
Sahores M; Prinetti A; Chiabrando G; Blasi F; Sonnino S
Biochim Biophys Acta; 2008 Jan; 1778(1):250-9. PubMed ID: 17963689
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.
Kiyan J; Smith G; Haller H; Dumler I
Biochem J; 2009 Oct; 423(3):343-51. PubMed ID: 19691446
[TBL] [Abstract][Full Text] [Related]
3. Lipid raft compartmentalization of urokinase receptor signaling in human neutrophils.
Sitrin RG; Johnson DR; Pan PM; Harsh DM; Huang J; Petty HR; Blackwood RA
Am J Respir Cell Mol Biol; 2004 Feb; 30(2):233-41. PubMed ID: 12933356
[TBL] [Abstract][Full Text] [Related]
4. Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions.
Cunningham O; Andolfo A; Santovito ML; Iuzzolino L; Blasi F; Sidenius N
EMBO J; 2003 Nov; 22(22):5994-6003. PubMed ID: 14609946
[TBL] [Abstract][Full Text] [Related]
5. uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors.
Montuori N; Cosimato V; Rinaldi L; Rea VE; Alfano D; Ragno P
Thromb Haemost; 2013 Feb; 109(2):309-18. PubMed ID: 23238745
[TBL] [Abstract][Full Text] [Related]
6. New Pieces in the Puzzle of uPAR Role in Cell Migration Mechanisms.
Gorrasi A; Petrone AM; Li Santi A; Alfieri M; Montuori N; Ragno P
Cells; 2020 Nov; 9(12):. PubMed ID: 33255171
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of lipid rafts with different properties from RBL-2H3 (rat basophilic leukaemia) cells.
Radeva G; Sharom FJ
Biochem J; 2004 May; 380(Pt 1):219-30. PubMed ID: 14769131
[TBL] [Abstract][Full Text] [Related]
8. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
9. Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction.
Yebra M; Goretzki L; Pfeifer M; Mueller BM
Exp Cell Res; 1999 Jul; 250(1):231-40. PubMed ID: 10388537
[TBL] [Abstract][Full Text] [Related]
10. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
11. The tyrosine phosphatase SHP-2 controls urokinase-dependent signaling and functions in human vascular smooth muscle cells.
Kiyan J; Haller H; Dumler I
Exp Cell Res; 2009 Apr; 315(6):1029-39. PubMed ID: 19133257
[TBL] [Abstract][Full Text] [Related]
12. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect.
Resnati M; Guttinger M; Valcamonica S; Sidenius N; Blasi F; Fazioli F
EMBO J; 1996 Apr; 15(7):1572-82. PubMed ID: 8612581
[TBL] [Abstract][Full Text] [Related]
13. Urokinase induces survival or pro-apoptotic signals in human mesangial cells depending on the apoptotic stimulus.
Tkachuk N; Kiyan J; Tkachuk S; Kiyan R; Shushakova N; Haller H; Dumler I
Biochem J; 2008 Oct; 415(2):265-73. PubMed ID: 18564064
[TBL] [Abstract][Full Text] [Related]
14. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein.
Zhang G; Cai X; López-Guisa JM; Collins SJ; Eddy AA
J Am Soc Nephrol; 2004 Aug; 15(8):2090-102. PubMed ID: 15284295
[TBL] [Abstract][Full Text] [Related]
15. Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.
Rasch MG; Pass J; Illemann M; Høyer-Hansen G; Lund IK
J Immunol Methods; 2008 Nov; 339(1):55-65. PubMed ID: 18761343
[TBL] [Abstract][Full Text] [Related]
16. Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells.
Raghu H; Sodadasu PK; Malla RR; Gondi CS; Estes N; Rao JS
BMC Cancer; 2010 Nov; 10():647. PubMed ID: 21106094
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of glycosphingolipids on the detergent-insolubility of the glycosylphosphatidylinositol-anchored membrane dipeptidase.
Parkin ET; Turner AJ; Hooper NM
Biochem J; 2001 Aug; 358(Pt 1):209-16. PubMed ID: 11485569
[TBL] [Abstract][Full Text] [Related]
18. The effects of cyclooxygenase2-prostaglandinE2 pathway on Helicobacter pylori-induced urokinase-type plasminogen activator system in the gastric cancer cells.
Iwamoto J; Mizokami Y; Takahashi K; Matsuoka T; Matsuzaki Y
Helicobacter; 2008 Jun; 13(3):174-82. PubMed ID: 18466392
[TBL] [Abstract][Full Text] [Related]
19. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
